Baltazar Gomez-Mancilla

Person

Basel, CH

People

Patents Grantslast 30 patents

Information Patent Grant
Use of mavoglurant in the reduction of cocaine use or in preventing...
- Patent number 11,878,001
- Issue date Jan 23, 2024
- Novartis AG
- Ricardo Carl Elciario Dolmetsch
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Biomarkers predictive of responsiveness to alpha 7 nicotinic acetyl...
- Patent number 11,359,241
- Issue date Jun 14, 2022
- Novartis AG
- Dominik Feuerbach
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Use of nicotinic acetylcholine receptor alpha 7 activators
- Patent number 11,096,916
- Issue date Aug 24, 2021
- Novartis AG
- Thérèse Di Paolo
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Use of nicotinic acetylcholine receptor alpha 7 activators
- Patent number 10,537,539
- Issue date Jan 21, 2020
- Novartis AG
- Thérèse Di Paolo
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Biomarkers predictive of responsiveness to alpha 7 nicotinic acetyl...
- Patent number 9,828,642
- Issue date Nov 28, 2017
- Novartis AG
- Dominik Feuerbach
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Combination products
- Patent number 8,703,809
- Issue date Apr 22, 2014
- Novartis AG
- Baltazar Gomez-Mancilla
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
USE OF MGLUR5 ANTAGONISTS FOR TREATING AMPHETAMINE ADDICTION
- Publication number 20240050408
- Publication date Feb 15, 2024
- Novartis AG
- Fabrizio GASPARINI
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BIOMARKER PREDICTIVE OF RESPONSIVENESS TO ALPHA 7 NICOTINIC ACETYLC...
- Publication number 20220316011
- Publication date Oct 6, 2022
- Novartis AG
- Dominik Feuerbach
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ALPHA 7 NICOTINIC ACETYLCHOLINE RECEPTOR AGONISTS
- Publication number 20220211679
- Publication date Jul 7, 2022
- Novartis AG
- Markus FENDT
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
THE USE OF AN MGLUR5 ANTAGONIST FOR TREATING OPIOID ANALGESIC TOLER...
- Publication number 20220175793
- Publication date Jun 9, 2022
- Novartis AG
- Richard Carl Elciario DOLMETSCH
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
USE OF NICOTINIC ACETYLCHOLINE RECEPTOR ALPHA 7 ACTIVATORS
- Publication number 20210338621
- Publication date Nov 4, 2021
- Novartis AG
- Therese Di Paolo
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
USE OF MAVOGLURANT IN THE REDUCTION OF COCAINE USE OR IN PREVENTING...
- Publication number 20210093609
- Publication date Apr 1, 2021
- Novartis AG
- Ricardo Carl Elciario Dolmetsch
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
USE OF MAVOGLURANT IN THE REDUCTION OF ALCOHOL USE OR IN PREVENTING...
- Publication number 20200237721
- Publication date Jul 30, 2020
- Novartis AG
- Ricardo Carl Elciario Dolmetsch
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
USE OF NICOTINIC ACETYLCHOLINE RECEPTOR ALPHA 7 ACTIVATORS
- Publication number 20200108035
- Publication date Apr 9, 2020
- Novartis AG
- Therese Di Paolo
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BIOMARKERS PREDICTIVE OF RESPONSIVENESS TO ALPHA 7 NICOTINIC ACETYL...
- Publication number 20180037957
- Publication date Feb 8, 2018
- Novartis AG
- Dominik Feuerbach
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
USE OF ALPHA 7 NICOTINIC ACETYLCHOLINE RECEPTOR AGONISTS
- Publication number 20170348294
- Publication date Dec 7, 2017
- Novartis AG
- Markus FENDT
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
USE OF ALPHA 7 NICOTINIC ACETYLCHOLINE RECEPTOR AGONISTS
- Publication number 20150313884
- Publication date Nov 5, 2015
- Novartis AG
- Markus FENDT
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BIOMARKERS PREDICTIVE OF RESPONSIVENESS TO ALPHA 7 NICOTINIC ACETYL...
- Publication number 20150275303
- Publication date Oct 1, 2015
- Novartis AG
- Dominik Feuerbach
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
ORGANIC COMPOUNDS
- Publication number 20150272929
- Publication date Oct 1, 2015
- Daniel Umbricht
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMBINATIONS OF ALPHA 7 NICOTINIC ACETYLCHOLINE RECEPTOR ACTIVATORS...
- Publication number 20140228398
- Publication date Aug 14, 2014
- Novartis AG
- Therese Di Paolo
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMBINATION PRODUCTS
- Publication number 20140194423
- Publication date Jul 10, 2014
- Baltazar Gomez-Mancilla
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
USE OF NICOTINIC ACETYLCHOLINE RECEPTOR ALPHA 7 ACTIVATORS
- Publication number 20140171448
- Publication date Jun 19, 2014
- Novartis AG
- Dominik Feuerbach
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Predictive Markers Useful in the Treatment of Fragile X Syndrome (FXS)
- Publication number 20130052644
- Publication date Feb 28, 2013
- Baltazar Gomez-Mancilla
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
USE OF NICOTINIC ACETYLCHOLINE RECEPTOR ALPHA 7 ACTIVATORS
- Publication number 20120172346
- Publication date Jul 5, 2012
- Novartis AG
- Thérèse Di Paolo
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
USE OF AZABICYCLOALKYL DERIVATIVES OR PYRROLIDINE-2-ONE DERIVATIVES...
- Publication number 20120157464
- Publication date Jun 21, 2012
- Novartis AG
- Dominik Feuerbach
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMBINATION PRODUCTS
- Publication number 20120122878
- Publication date May 17, 2012
- Baltazar Gomez-Mancilla
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMBINATIONS FOR THE TREATMENT OF MIGRAINE
- Publication number 20110212980
- Publication date Sep 1, 2011
- Novartis AG
- Graeme Bilbe
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ORGANIC COMPOUNDS
- Publication number 20100249136
- Publication date Sep 30, 2010
- Daniel Umbricht
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Baltazar Gomez-Mancilla

Person

Patents Grantslast 30 patents

Use of mavoglurant in the reduction of cocaine use or in preventing...

Biomarkers predictive of responsiveness to alpha 7 nicotinic acetyl...

Use of nicotinic acetylcholine receptor alpha 7 activators

Use of nicotinic acetylcholine receptor alpha 7 activators

Biomarkers predictive of responsiveness to alpha 7 nicotinic acetyl...

Combination products

Patents Applicationslast 30 patents

USE OF MGLUR5 ANTAGONISTS FOR TREATING AMPHETAMINE ADDICTION

BIOMARKER PREDICTIVE OF RESPONSIVENESS TO ALPHA 7 NICOTINIC ACETYLC...

ALPHA 7 NICOTINIC ACETYLCHOLINE RECEPTOR AGONISTS

THE USE OF AN MGLUR5 ANTAGONIST FOR TREATING OPIOID ANALGESIC TOLER...

USE OF NICOTINIC ACETYLCHOLINE RECEPTOR ALPHA 7 ACTIVATORS

USE OF MAVOGLURANT IN THE REDUCTION OF COCAINE USE OR IN PREVENTING...

USE OF MAVOGLURANT IN THE REDUCTION OF ALCOHOL USE OR IN PREVENTING...

USE OF NICOTINIC ACETYLCHOLINE RECEPTOR ALPHA 7 ACTIVATORS

BIOMARKERS PREDICTIVE OF RESPONSIVENESS TO ALPHA 7 NICOTINIC ACETYL...

USE OF ALPHA 7 NICOTINIC ACETYLCHOLINE RECEPTOR AGONISTS

USE OF ALPHA 7 NICOTINIC ACETYLCHOLINE RECEPTOR AGONISTS

BIOMARKERS PREDICTIVE OF RESPONSIVENESS TO ALPHA 7 NICOTINIC ACETYL...

ORGANIC COMPOUNDS

COMBINATIONS OF ALPHA 7 NICOTINIC ACETYLCHOLINE RECEPTOR ACTIVATORS...

COMBINATION PRODUCTS

USE OF NICOTINIC ACETYLCHOLINE RECEPTOR ALPHA 7 ACTIVATORS

Predictive Markers Useful in the Treatment of Fragile X Syndrome (FXS)

USE OF NICOTINIC ACETYLCHOLINE RECEPTOR ALPHA 7 ACTIVATORS

USE OF AZABICYCLOALKYL DERIVATIVES OR PYRROLIDINE-2-ONE DERIVATIVES...

COMBINATION PRODUCTS

COMBINATIONS FOR THE TREATMENT OF MIGRAINE

ORGANIC COMPOUNDS